These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1117 related articles for article (PubMed ID: 3744640)

  • 1. Effect of tumor inhibitory and stimulatory doses of levan, alone and in combination with cyclophosphamide, on spleen and lymph nodes.
    Leibovici J; Kopel S; Siegal A; Gal-Mor O
    Int J Immunopharmacol; 1986; 8(4):391-403. PubMed ID: 3744640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cyclophosphamide and levan treatment on bone marrow and peripheral blood cells in B16-F10 melanoma-bearing mice.
    Leibovici J; Siegal A; Kopel S; Davidai G; Yavetz H
    Int J Immunopharmacol; 1989; 11(2):133-47. PubMed ID: 2703278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological changes in spleen and lymph nodes of mice administered cyclophosphamide and levan.
    Siegal A; Kopel S; Leibovici J
    Cell Tissue Res; 1986; 245(1):183-8. PubMed ID: 3488127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite effects on tumor growth depending on dose of an immunomodulatory polysaccharide with or without cyclophosphamide.
    Leibovici J; Kopel S; Wolman M
    Anticancer Res; 1985; 5(5):553-8. PubMed ID: 4062258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the tuberculin reaction by levan.
    Shezen E; Leibovici J; Wolman M
    Br J Exp Pathol; 1978 Oct; 59(5):454-8. PubMed ID: 718799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow and peripheral blood modifications in C57BL mice administered with cyclophosphamide and levan.
    Siegal A; Kopel S; Bar-Sela S; Davidai G; Yavetz H; Leibovici J
    In Vivo; 1988; 2(5):349-59. PubMed ID: 2979857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory and stimulatory effects of levan on growth of B16 melanoma--possible mechanisms.
    Yavetz H; Davidai G; Leibovici J; Wolman M
    Cell Mol Biol; 1985; 31(5):343-7. PubMed ID: 4084939
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of administration schedule on the levan-cyclophosphamide combined treatment of Lewis lung carcinoma.
    Stark Y; Leibovici J; Wolman M
    Int J Immunopharmacol; 1983; 5(4):289-97. PubMed ID: 6629589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effect of levan and cytotoxic agents on the growth of experimental tumours in mice.
    Leibovici J; Stark Y; Wolman M
    Br J Exp Pathol; 1983 Jun; 64(3):239-44. PubMed ID: 6882675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of splenectomy on treatment of Lewis lung carcinoma by an immunomodulatory polysaccharide and a cytotoxic agent.
    Michowitz M; Kopel S; Hoenig S; Leibovici J
    J Surg Oncol; 1987 Apr; 34(4):268-71. PubMed ID: 3560964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of splenectomy on the efficiency of chemo-immunotherapy of melanoma-bearing mice.
    Kopel S; Michowitz M; Leibovici J
    Int J Immunopharmacol; 1985; 7(6):801-10. PubMed ID: 4077343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of humoral immune response in mice by administration of high molecular levan.
    Hoenig S; Katzap I; Leibovici J
    Experientia; 1978 Oct; 34(10):1362-3. PubMed ID: 738425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change from inhibition to stimulation by levan of AKR lymphoma following serial transfers.
    Leibovici J; Hoenig S; Stark Y; Kopel S; Wolman M
    Exp Cell Biol; 1984; 52(4):219-24. PubMed ID: 6734889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct antitumor effect of the polysaccharide levan in mice: effects of drug concentration and time and temperature of incubation.
    Leibovici J; Stark Y
    J Natl Cancer Inst; 1984 Jun; 72(6):1417-20. PubMed ID: 6587158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory effects of high molecular levan on transport across the vascular wall stimulated by histamine.
    Walters MN; Wolman M; Robertson TA; Papadimitriou JM
    J Pathol; 1978 Apr; 124(4):195-203. PubMed ID: 722383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anamnestic responses induced by antigen persisting on follicular dendritic cells from cyclophosphamide-treated mice.
    Phipps RP; Mandel TE; Schnizlein CT; Tew JG
    Immunology; 1984 Feb; 51(2):387-97. PubMed ID: 6607214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells.
    Palomares T; Alonso-Varona A; Alvarez A; Castro B; Calle Y; Bilbao P
    Clin Exp Metastasis; 1997 May; 15(3):329-37. PubMed ID: 9174132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite effects on tumor growth depending on dose of Achyranthes bidentata polysaccharides in C57BL/6 mice.
    Jin LQ; Zheng ZJ; Peng Y; Li WX; Chen XM; Lu JX
    Int Immunopharmacol; 2007 May; 7(5):568-77. PubMed ID: 17386404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of HDAC inhibitor MS-275 and IL-2 increased anti-tumor effect in a melanoma model via activated cytotoxic T cells.
    Kato Y; Yoshino I; Egusa C; Maeda T; Pili R; Tsuboi R
    J Dermatol Sci; 2014 Aug; 75(2):140-7. PubMed ID: 24866536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of the polysaccharide levan on the oncogenicity of cells of two variants of Lewis lung carcinoma.
    Stark Y; Leibovici J
    Br J Exp Pathol; 1986 Feb; 67(1):141-7. PubMed ID: 3947532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.